{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:04:04Z","timestamp":1785683044773,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.humpath.2024.06.008","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:22:03Z","timestamp":1718299323000},"page":"66-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia"],"prefix":"10.1016","volume":"149","author":[{"given":"Ahmed","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juehua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Abaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Vormittag-Nocito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madina","family":"Sukhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2024.06.008_bib1","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","article-title":"Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML","volume":"368","author":"Maxson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2024.06.008_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJM199508243330804","article-title":"Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia","volume":"333","author":"Dong","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2024.06.008_bib3","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1002\/cncr.31586","article-title":"CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia","volume":"124","author":"Zhang","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2024.06.008_bib4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.06.008_bib5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.06.008_bib6","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1182\/blood-2013-05-500959","article-title":"The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment","volume":"122","author":"Gotlib","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.06.008_bib7","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1080\/10428194.2023.2227750","article-title":"CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature","volume":"64","author":"Guastafierro","year":"2023","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2024.06.008_bib8","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.06.008_bib9","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.3324\/haematol.2013.085050","article-title":"Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia","volume":"98","author":"Beekman","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2024.06.008_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exphem.2016.10.008","article-title":"Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies","volume":"46","author":"Dwivedi","year":"2017","journal-title":"Exp Hematol"},{"key":"10.1016\/j.humpath.2024.06.008_bib11","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1182\/bloodadvances.2020002013","article-title":"Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies","volume":"4","author":"Trottier","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2024.06.008_bib12","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1111\/bjh.19315","article-title":"CSF3R P733T is a deleterious germline variant in acute leukaemia showing gain-of-function-like T618I mutation","volume":"204","author":"Sun","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.06.008_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1182\/blood-2016-10-695981","article-title":"Genomics of chronic neutrophilic leukemia","volume":"129","author":"Maxson","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.06.008_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ng.2495","article-title":"Recurrent SETBP1 mutations in atypical chronic myeloid leukemia","volume":"45","author":"Piazza","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2024.06.008_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171608","article-title":"Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: a meta-analysis","volume":"12","author":"Shou","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2024.06.008_bib16","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/leu.2013.122","article-title":"CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia","volume":"27","author":"Pardanani","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.06.008_bib17","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/leu.2013.182","article-title":"Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia","volume":"27","author":"Kosmider","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.06.008_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41375-019-0567-9","article-title":"Altered expression of CSF3R splice variants impacts signal response and is associated with SRSF2 mutations","volume":"34","author":"Lance","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.06.008_bib19","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/s41375-022-01672-4","article-title":"Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms","volume":"36","author":"Wang","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.06.008_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41408-018-0058-7","article-title":"CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival","volume":"8","author":"Szuber","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.humpath.2024.06.008_bib21","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1182\/bloodadvances.2022008204","article-title":"CNL and aCML should be considered as a single entity based on molecular profiles and outcomes","volume":"7","author":"Carreno-Tarragona","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2024.06.008_bib22","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1182\/bloodadvances.2023010722","article-title":"CNL and aCML are prognostically distinct: a large National Cancer Database analysis","volume":"7","author":"Tremblay","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2024.06.008_bib23","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1200\/JCO.19.00895","article-title":"Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia","volume":"38","author":"Dao","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2024.06.008_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ajh.24031","article-title":"ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia","volume":"90","author":"Elliott","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2024.06.008_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-014-0077-1","article-title":"CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia","volume":"7","author":"Cui","year":"2014","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.humpath.2024.06.008_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOH.0000000000000114","article-title":"Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice","volume":"22","author":"Tefferi","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.humpath.2024.06.008_bib27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/blood.2021014777","article-title":"Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms","volume":"140","author":"Carratt","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.06.008_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood.2019000611","article-title":"Genomic landscape of neutrophilic leukemias of ambiguous diagnosis","volume":"134","author":"Zhang","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.06.008_bib29","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1182\/blood-2016-04-709899","article-title":"CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML","volume":"127","author":"Maxson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.06.008_bib30","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1182\/blood-2016-03-705053","article-title":"Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors","volume":"127","author":"Lavallee","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.06.008_bib31","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1182\/bloodadvances.2021004668","article-title":"Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies","volume":"5","author":"Stengel","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2024.06.008_bib32","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood.2019004229","article-title":"Molecular landscape and clonal architecture of adult myelodysplastic\/myeloproliferative neoplasms","volume":"136","author":"Palomo","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.06.008_bib33","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1038\/leu.2015.91","article-title":"Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms","volume":"29","author":"Molenaar","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.06.008_bib34","article-title":"Rare evolution of CSF3R-mutated chronic neutrophilic leukemia to t(4;12)(q12;p13) acute myeloid leukemia with SETBP1 mutation","volume":"17","author":"Hirao","year":"2022","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.humpath.2024.06.008_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ajh.26481","article-title":"Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management","volume":"97","author":"Szuber","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2024.06.008_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891961","article-title":"Chronic neutrophilic leukemia: a comprehensive review of clinical characteristics, genetic landscape and management","volume":"12","author":"Thomopoulos","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2024.06.008_bib37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2403562","article-title":"WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature","volume":"19","author":"Elliott","year":"2005","journal-title":"Leukemia"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T22:04:05Z","timestamp":1720994645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817724001096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":37,"alternative-id":["S0046817724001096"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.06.008","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}